Hikal signs Rs 200 cr pact with Alpharma Inc

Monday, July 9, 2007, 14:07 [IST]

New Delhi, July 9: Drug and chemicals maker Hikal Ltd today said it has signed a mutually exclusive long-term agreement worth Rs 200 crore with US-based Alpharma Inc.

The agreement includes manufacture and supply of an Active Pharmaceutical Ingredient (API) for the Veterinary sector.

Hikal will manufacture the API at its US Food and Drug Authority-approved plant at Jigani, Bangalore.

UNI

Topics: new delhi, hikal ltd, united states, api

Other articles published on July 9, 2007

Limitless Updates

Business News

News Archives

Palm tops for TTEs for feed on vacant berths

Monday, February 26, 2007,18:53 [IST]

New Delhi, Feb 26: Palm tops will be given to Railway Travelling Ticket Examiners(TTEs) so that they can feed to the Passenger Reservation System (PRS), the information about berths/seats falling vacant at the eleventh hour.Under the existing system, reservation charts are brought out a few hours before the departure of trains. Often due to unforeseen circumstances, several passengers with reservations do not travel, resulting in many berths remaining vacant.Since this information is not fed into the PRS.....